HomeSIGY • OTCMKTS
add
Sigyn Therapeutics Inc
Previous close
$1.99
Year range
$1.91 - $5.70
Market cap
3.19M USD
Avg Volume
922.00
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
TSLA
2.28%
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 469.51K | -22.11% |
Net income | -1.45M | -68.28% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -469.51K | 21.94% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 459.00 | -99.14% |
Total assets | 51.76K | -83.83% |
Total liabilities | 5.49M | 37.50% |
Total equity | -5.44M | — |
Shares outstanding | 1.61M | — |
Price to book | -0.59 | — |
Return on assets | -792.91% | — |
Return on capital | 44.29% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -1.45M | -68.28% |
Cash from operations | -152.44K | 16.61% |
Cash from investing | — | — |
Cash from financing | 140.00K | -31.24% |
Net change in cash | -12.44K | -159.77% |
Free cash flow | 97.95K | -30.94% |
About
Founded
2014
Website
Employees
4